In addition to providing coverage of these drugs for obesity, which would be a new indication in Medicare and in most states under Medicaid, these efforts will also allow beneficiaries in participating states and Part D plans to access GLP-1s for obesity at a lower out-of-pocket cost than if they were to purchase them with cash at the direct-to-consumer prices offered by the manufacturers
Learn how oncology biosimilar developers can encourage uptake and navigate other development challenges, in ICONs article by Kimberly Salgado in Drug Discovery & Development magazine
Research suggests glutathione levels naturally decline with age, potentially affecting cellular resilience and oxidative stress management in aging populations
Mol Metab (2019) 21:5167
Comment: A few commenters stated that the requirement for anonymity limits their ability to use the survey data to investigate any issues identified and ( to develop targeted action plans and quality improvement efforts, which defeats the purpose of the measure
Ask whether GLP-1 medications for weight loss are explicitly covered, whether prior authorization is required, and exactly what documentation your provider must submit
.png)
